Big Data Skills Sustainable Development in Healthcare and Pharmaceuticals
Open Access
- 9 October 2020
- journal article
- research article
- Published by Springer Nature in Journal of Medical Systems
- Vol. 44 (11) , 1-15
Abstract
Big Data technology is one of the most promising organizational processes within the Healthcare and Pharmaceutical industry and crucial for any company that wants to preserve the competitive advantage in the market, where most of the organizational structures are already struggling with the right skills and knowledge to fully support existing business needs for storing and processing and even analyzing information. This paper aims to examine the extent to which new Big Data technology and data-related processes are developing different professionals skills and competencies within the Healthcare and Pharmaceutical industries, and creating sustainable development in addressing critical organizational challenges in recruiting, retaining, and discover professional skills that can fully support the advances and exponential growth of Big Data technology benefits. This research paper also highlights the significant aspects of Big Data in professional technical and process oriented skills development, and the influence it has on organizational business processes including how various internal functions will need to adapt to new circumstances with renewed competency and skills development programs for departments that are strongly connected to the business and analytical needs. We conducted a focus group with twenty-five industry based professionals’ ranges from analysts to executive directors to better assess the necessary knowledge to answer the proposed research questions: (1) which professional skills can big data influence in employee development and (2) how can organizations adapt their employee skills to big data. Regarding the key research limitations/implications most of the article and research was built on the foundation of the literature review and the performed focus group. The conceptual recommendations and observations presented provide solid empirical evidence but should be subjected to more comprehensive, large-scale empirical testing and validation. It’s recommended for future research a more extensive sample of companies, organizations, and interviewees. Studying a broader set of similar research questions in more homogeneous organizations could provide deeper insights into the process, governance, and stakeholder dimensions of Big Data within specific contexts. Therefore this study contributes to explore in-depth and systematically to what extent Big Data technology and processes are currently influencing the healthcare and pharmaceuticals industries where to the best of the authors’ knowledge, it is the first focus group dealing with the presented research questions.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UIDB/00315/2020)
This publication has 27 references indexed in Scilit:
- Big data analytics: Understanding its capabilities and potential benefits for healthcare organizationsTechnological Forecasting and Social Change, 2018
- Digitalization: Opportunity and Challenge for the Business and Information Systems Engineering CommunityBusiness & Information Systems Engineering, 2017
- Mundane data: The routines, contingencies and accomplishments of digital livingBig Data & Society, 2017
- Data ideologies of an interested public: A study of grassroots open government data intermediariesBig Data & Society, 2017
- Stability-driven nonnegative matrix factorization to interpret spatial gene expression and build local gene networksProceedings of the National Academy of Sciences, 2016
- Digital Transformation StrategiesBusiness & Information Systems Engineering, 2015
- Cybersecurity vulnerabilities in medical devices: a complex environment and multifaceted problemMedical Devices: Evidence and Research, 2015
- The next digital transformation: from an individual-centered to an everyone-to-everyone economyStrategy & Leadership, 2014
- The Lysosomal v-ATPase-Ragulator Complex Is a Common Activator for AMPK and mTORC1, Acting as a Switch between Catabolism and AnabolismCell Metabolism, 2014
- Probes of the small x gluon via exclusive J/ψ and Υ production at HERA and the LHCJournal of High Energy Physics, 2013